Possible Involvement of Inositol 1,4,5-Trisphosphate Receptor Type 3 (IP3R3) in the Peritoneal Dissemination of Gastric Cancers

Anticancer Research

Volumn 23, Issue 5 A, 2003, Pages 3691-3697

  Sakakura, Chouhei ^a   Hagiwara, Akeo ^a   Fukuda, Kenichiro ^a   Shimomura, Katsumi ^a   Takagi, Tsuyoshi ^a   Kin, Shuichi ^a   Nakase, Yuenn ^a   Fujiyama, Junshin ^a,c   Mikoshiba, Katsuhiko ^b   Okazaki, Yasushi ^c   Yamagishi, Hisakazu ^a  

^a KYOTO PREFECTURAL UNIVERSITY OF MEDICINE   (Japan)

^b INST OF PHYS AND CHEMICAL RESEARCH   (Japan)

^c RIKEN YOKOHAMA INSTITUTE   (Japan)

Author keywords

Gastric cancer; IP3R3; Peritoneal dissemination

Indexed keywords

2 AMINOETHOXYDIPHENYLBORANE; BORINIC ACID DERIVATIVE; CALCIUM ION; INOSITOL 1,4,5 TRISPHOSPHATE RECEPTOR; PROTEINASE; UNCLASSIFIED DRUG;

ARTICLE; ASCITES; CALCIUM TRANSPORT; CANCER INHIBITION; CELL LINE; CONCENTRATION (PARAMETERS); EPITHELIUM CELL; HUMAN; HUMAN CELL; LEUKEMIA CELL; LIVER METASTASIS; LYMPH NODE METASTASIS; METASTASIS; PERITONEUM; PRIORITY JOURNAL; PROTEIN EXPRESSION; SECRETION; SIGNAL TRANSDUCTION; STOMACH CANCER; TUMOR;

APOPTOSIS; BLOTTING, WESTERN; BORON COMPOUNDS; CALCIUM CHANNELS; CELL DIVISION; CELL LINE, TUMOR; DOSE-RESPONSE RELATIONSHIP, DRUG; HUMANS; INOSITOL 1,4,5-TRISPHOSPHATE RECEPTORS; PERITONEAL NEOPLASMS; RECEPTORS, CYTOPLASMIC AND NUCLEAR; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; STOMACH NEOPLASMS;

EID: 10744233873     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (30)

1. Parkin DM, Pisani P and Ferlay J: Estimates of the worldwide incidence of 25 major cancers in 1990. Int J Cancer 80: 827-841, 1999.
2. Yamazaki H, Oshima A, Murakami R, Endoh S and Ubukata T: A long-term follow-up study of patients with gastric cancer detected by mass screening. Cancer 63: 613-7, 1989.
3. Shimada K and Ajani JA: Adjuvant therapy for gastric carcinoma patients in the past 15 years: a review of western and oriental trials. Cancer 1: 1657-1668, 1999.
4. Tahara E, Semba S and Tahara H: Molecular biological observations in gastric cancer. Semin Oncol 23: 307-15, 1996.
5. Yawata A, Adachi M, Okuda H, Naishiro Y, Takamura T, Hareyama M, Takayama S, Reed JC and Imai K: Prolonged cell survival enhances peritoneal dissemination of gastric cancer cells. Oncogene 16: 2681-2686, 1998.
6. Sakakura C, Hagiwara A, Nakanishi M, Shimomura K, Takagi T, Yasuoka R, Fujita Y, Abe T, Ichikawa Y, Takahashi S, Ishikawa T, Nishizuka I, Morita T, Shimada H, Okazaki Y, Hayashizaki Y and Yamagishi H: Differential gene expression profiles of gastric cancer cells established from primary tumour and malignant ascites. Br J Cancer 87: 1153-61, 2002.
7. Berridge MJ: Inositol trisphosphate and calcium signalling. Nature 361: 315-25, 1993.
8. 2+ signaling in the brain. J Neurochem 64: 953-60, 1995.
9. Furuichi T, Kohda K, Miyawaki A and Mikoshiba K: Intracellular channels. Curr Opin Neurobiol 4: 294-303, 1994.
10. Clapham DE: Calcium signaling. Cell 80: 259-68, 1995.
11. Patel S, Joseph SK and Thomas AP: Molecular properties of inositol 1,4,5-trisphosphate receptors. Cell Calcium 25: 247-64, 1999.
12. Park JG, Frucht H, LaRocca RV, Bliss DP Jr, Kurita Y, Chen TR, Henslee JG, Trepel JB, Jensen RT and Johnson BE: Characteristics of cell lines established from human gastric carcinoma. Cancer Res 50: 2773-80, 1990.
13. Park JG, Yang HK, Kim WH, Chung JK, Kang MS, Lee JH, Oh JH, Park HS, Yeo KS, Kang SH, Song SY, Kang YK, Bang YJ, Kim YH and Kim JP: Establishment and characterization of human gastric carcinoma cell lines. Int J Cancer 70: 443-9, 1997.
14. Park K, Kim SJ, Bang YJ, Park JG, Kim NK, Roberts AB and Sporn MB: Genetic changes in the transforming growth factor beta (TGF-beta) type II receptor gene in human gastric cancer cells: correlation with sensitivity to growth inhibition by TGF-beta. Proc Natl Acad Sci USA 91: 8772-6, 1994.
15. Sekiguchi M, Sakakibara K and Fujii G: Establishment of cultured cell lines derived from human gastric carcinoma. Jap J Exp Med 48: 61-68, 1978.
16. Tamura G, Sakata K, Nishizuka S, Maesawa C, Suzuki Y, Iwaya T, Terashima M, Saito K and Satodate R: Inactivation of the E-cadherin gene in primary gastric carcinomas and gastric carcinoma cell lines. Jpn J Cancer Res 87: 1153-9, 1996.
17. Hojo H: Establishment of cultured cell lines of human stomach cancer origin and their morphological characteristics. Niigata Igakkai Zasshi 91: 737-763, 1977 (in Japanese).
18. Sakakura C, Ymaguchi-Iwai Y, Satake M, Bae SC, Takahashi A, Ogawa E, Hagiwara A, Takahashi T, Murakami A, Makino K, NakagawaA T, Kamada N and Ito Y: Growth inhibition and induction of differentiation of t(8;21) acute myeloid leukemia cells by the DNA-binding domain of PEBP2 and the AML1/MTG8(ETO)-specific antisense oligonucleotide. Proc Natl Acad Sci USA 91: 11723-11727, 1994.
19. Sakakura C, Sweeney EA, Shirahama T, Igarashi Y, Hakomori S, Nakatani H, Tsujimoto H, Imanishi T, OhgakiH M, Ohyama T, Yamazaki J and Hagiwara A, Yamaguchi T, Sawai K and Takahashi T: Overexpression of bax sensitizes human breast cancer MCF-7 cells to radiation-induced apoptosis. Int J Cancer 67: 101-105, 1996.
20. Kodera Y, Nakanishi H, Ito S, Yamamura Y, Kanemitsu Y, Shimizu Y, Hirai T, Yasui K, Kato T and Tatematsu M: Quantitative detection of disseminated free cancer cells in peritoneal washes with real-time reverse transcriptase-polymerase chain reaction: a sensitive predictor of outcome for patients with gastric carcinoma. Ann Surg 235: 499-506, 2002.
21. Kreuzer K A, Lass U, Landt O, Nitsche A, Laser J, Ellerbrok H, Pauli G, Huhn D and Schmidt CA: Highly sensitive and specific fluorescence reverse transcription-PCR assay for the pseudogene-free detection of β-actin transcripts as quantitative reference. Clin Chem 45: 297-300, 1999.
22. Sakakura C, Sweeney EA, Shirahama T, Hakomori S and Igarashi Y: Suppression of bcl-2 gene expression by sphingosine in the apoptosis of human leukemic HL-60 cells during phorbol ester-induced terminal differentiation. FEBS Lett 379: 177-80, 1996.
23. Kuroda Y, Kaneko S, Yoshimura Y, Nozawa S and Mikoshiba K: Are there inositol 1,4,5-triphosphate (IP3) receptors in human sperm? Life Sci 65: 135-43, 1999.
24. Bolton TB, Prestwich SA, Zholos AV and Gordienko DV: Excitation-contraction coupling in gastrointestinal and other smooth muscles. Annu Rev Physiol 61: 85-115, 1999.
25. Bitar KN and Yamada H: Modulation of smooth muscle contraction by sphingosylphosphorylcholine. Am J Physiol 269: 370-7, 1995.
26. Felzen B, Shilkrut M, Less H, Sarapov I, Maor G, Coleman R, Robinson RB, Berke G and Binah O: Fas (CD95/Apo-1)-mediated damage to ventricular myocytes induced by cytotoxic T lymphocytes from perforin-deficient mice: a major role for inositol 1,4,5-trisphosphate. Circ Res 82: 438-50, 1998.
27. Lail-Trecker MR, Peluso CE and Peluso JJ: Hepatocyte growth factor disrupts cell contact and stimulates an increase in type 3 inositol triphosphate receptor expression, intracellular calcium levels, and apoptosis of rat ovarian surface epithelial cells. Endocrine 12: 303-314, 2000.
28. 2+ release. J Biochem (Tokyo). 122: 498-505, 1997.
29. Wu J, Kamimura N, Takeo T, Suga S, Wakui M, Maruyama T and Mikoshiba K: 2-Aminoethoxydiphenyl borate modulates kinetics of intracellular Ca(2+) signals mediated by inositol 1,4,5-trisphosphate-sensitive Ca(2+) stores in single pancreatic acinar cells of mouse. Mol Pharmacol 58: 1368-74, 2000.
30. 2+ release modulator, 2APB, in rat pancreatic acinar cells. Biomedical Res 18: 297-302, 1997.